Balyasny Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,055
| Closed | -$351K | – | 1726 |
|
|
2018
Q3 | $351K | Buy |
2,055
+905
| +79% | +$155K | ﹤0.01% | 1245 |
|
|
2018
Q2 | $200K | Sell |
1,150
-211,395
| -99% | -$36.8M | ﹤0.01% | 1467 |
|
|
2018
Q1 | $24.5M | Sell |
212,545
-169,295
| -44% | -$19.5M | 0.1% | 247 |
|
|
2017
Q4 | $32.1M | Buy |
381,840
+354,560
| +1,300% | +$29.8M | 0.1% | 246 |
|
|
2017
Q3 | $2.51M | Sell |
27,280
-190,353
| -87% | -$17.5M | 0.01% | 737 |
|
|
2017
Q2 | $17.5M | Buy |
217,633
+12,664
| +6% | +$1.02M | 0.07% | 313 |
|
|
2017
Q1 | $8.63M | Buy |
204,969
+141,329
| +222% | +$5.95M | 0.04% | 475 |
|
|
2016
Q4 | $2.04M | Buy |
+63,640
| New | +$2.04M | 0.01% | 704 |
|
|
2016
Q1 | – | Sell |
-27,550
| Closed | -$784K | – | 1433 |
|
|
2015
Q4 | $784K | Buy |
+27,550
| New | +$784K | 0.01% | 617 |
|